GLG News Analyses of the following article:
TNF blockers linked to cancer risk in children & teens
Published at: benkazie.wordpress.com
-
TNF blockers linked to cancer risk in children & teens
August 5, 2009
The Food and Drug Administration said Tuesday there’s an increased risk of lymphoma and other cancers associated with the use of drugs like Remicade [infliximab] and Humira [adalimumab] in children and adolescents. The FDA is requiring stronger warnings regarding the risk for cancer associated with tumor necrosis factor (TNF) blockers.
- Subscribe to Updates
-
Work for one of the world's leading organizations? Get started now.
Get Intelligently Connected
with the world's leading experts
GLG's 850+ Clients Include:
- More than 70% of the world's leading
- mutual funds
- 15 of the leading 20
- global banks
- 9 of the leading 10
- global private equity firms
- 5 of the leading 10
- AmLaw firms
- Fortune 500® Companies
- in nearly every industry sector, including pharmaceuticals, insurance, chemicals, energy and computer software
Gerson Lehrman Group, Inc. connects communities with knowledge through two distinct, yet complementary offerings: GLG Research and G+.